Clinical Evaluation of an Innovative Non-contact Optical Device for Skin Oxygenation Imaging

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-03

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

According to international consensus, information on the level of skin oxygenation is necessary for the diagnostic management of chronic wounds. The measurement of transcutaneous partial oxygen pressure (or TcPO2, according to the acronym) is measurable with a medical device that uses a Clark electrode. Since the medical device in question is expensive and the measurement time-consuming (approximately 45 minutes per patient), the TcPO2 is only rarely accessible (in hospital medicine as in nursing homes) and is therefore not predominant in the clinical decision. The clinical decision is currently mainly based on the result of the ankle blood pressure measurement, which is readily available.

The main objective is to study, from the same skin surfaces (same localization of skin sites and same dimensions of each surface in cm²), in patients with cutaneous vascular disorders or chronic wounds, the relationship between (i) the transcutaneous oxygen saturation values (expressed as a percentage) by the innovative non-contact optical imaging device under study (IPAM, method to be validated) and (ii) the transcutaneous partial oxygen pressure values (TcPO2) (expressed in millimeters of mercury, mmHg) measured by the reference medical device (Périflux6000, gold standard).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Tissue Perfusion and Blood Flow Monitoring Technology

NCT01139567

Wounds and Injuries

COMPLETED

N600X Low Saturation Accuracy Validation

NCT05532670

Hypoxia

COMPLETED

Controlled Desaturation Study for Perin Health Patch Validation

NCT06680700

Oxygen Saturation Measurement

RECRUITING

ORI to Reduce Hyperoxia After Out Hospital Cardiac Arrest

NCT03653325

Out-Of-Hospital Cardiac Arrest Oxygen Toxicity

COMPLETED NA

Non-invasive Technology for Early Signal Detection of Hypoxemia With ORI During Intubation

NCT03600181

Intubation Complication

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The InnovaTICs Dépendance project, funded by the Grand Region Is, aims to develop a medical device meeting the need to measure quickly and non-invasively the skin oxygen saturation. To do this, a device medical was developed by CRAN (Joint Research Unit of the University of Lorraine and CNRS); its industrial transfer was entrusted to the company SD Innovation to produce the VRPC device for "video-reconstruction of chronic wounds". The VRPC medical device makes it possible to measure skin oxygen saturation by an optical (atraumatic) and non-contact (non-invasive) method, more quickly than the current method proposes. The capacity of the VRPC device to measure in vivo variations in skin oxygen saturation was confirmed by carrying out measurements on healthy volunteers. The measured values made it possible to show that the VRPC device was able to detect the difference in skin oxygen saturation between the skin covering a "healthy" finger and the skin covering the same finger but after a tourniquet had been placed at the base of the first phalanx of the finger (data not published).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Wounds Obliterating Arteriopathy of the Lower Limbs

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oxygen cutaneous saturation rate (ScO2) then transcutaneous oxygen partial pressure (TcPO2)

ScO2 values will be measured using IPAM first then TcPO2 values will be measured using Periflux6000. ALways in the same order.

Group Type EXPERIMENTAL

Oxygen saturation measurement using the IPAM device

Intervention Type DEVICE

Skin oxygen saturation rate will be measured (%) using the non-contact optical device under evaluation called IPAM

Transcutaneous oxygen partial pressure (TcPO2) using the PeriFlux6000 device

Intervention Type DEVICE

Skin TcPO2 will be measured (mmHg) using the reference device called PeriFlux6000

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxygen saturation measurement using the IPAM device

Skin oxygen saturation rate will be measured (%) using the non-contact optical device under evaluation called IPAM

Intervention Type DEVICE

Transcutaneous oxygen partial pressure (TcPO2) using the PeriFlux6000 device

Skin TcPO2 will be measured (mmHg) using the reference device called PeriFlux6000

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major,
* Having signed the informed consent to participate in the clinical study
* Compulsory affiliation to a social security scheme
* Presenting at least one of the following two criteria:

* Presence of a PAD at the stage of Chronic Critical Ischemia (CHF) of stage III or IV according to the classification of Leriche and Fontaine,
* Presence of one (or more) chronic wound (s) of the lower limbs of the pressure sore or ulcer type.

Exclusion Criteria

* Person referred to in Articles L. 1121-5, L1121-6, L. 1121-7 and L1121-8 of the Public Health Code.
* Pregnant woman, parturient or nursing mother
* Minor (non-emancipated)
* Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice)
* Person of full age unable to express consent
* Persons deprived of their liberty by a judicial or administrative decision, persons undergoing psychiatric treatment under Articles L.3212-1 and L. 3213-1.

Eligible Sex

ALL

Accepts Healthy Volunteers

No